Category: Stem Cell Research

A human embryonic stem cell is reined in - prevented from giving up its unique characteristics of self-renewal and pluripotency - by the presence of a protein modification that stifles any genes that would prematurely instruct the cell to develop into heart or other specialized tissue.

Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer. In Seattle, Washington, researchers at the University of Washington and Fred Hutchinson Cancer Research Center believe they have identified a source of this protective effect: fetal cells “transplanted” to the mother before birth.

The South Korean Ministry of Health and Welfare on Thursday announced it will allow scientists to conduct research on creating embryonic stem cells by cloning human embryos, the AP/West Australian reports (AP/West Australian, 9/27).

Stem Cell Sciences plc (SCS; AIM:STEM, ASX: STC) announces that it is to lead an EU funded, multinational novel drug screening collaboration using stem cells. The project, named “NEUROscreen”, will use Stem Cell Sciences’ proprietary neural stem (NS) cell technology and has received a contribution from the EU’s 6th Framework Programme for Research and Technical Development (FP6). The EU’s contribution to the NEUROscreen project is worth €2.

Ten faculty members at the Albert Einstein College of Medicine of Yeshiva University will be honored at a special academic convocation on Tuesday, October 9, at the medical school. They will be invested in newly endowed named professorships made possible by major philanthropic contributions to the College of Medicine.Richard M. Joel, president of Yeshiva University, and Dr. Allen M. Spiegel, The Marilyn and Stanley M.

Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington’s disease — a fatal disorder for which there is currently no cure or even a treatment to slow the disease.In a paper published in the Journal of Clinical Investigation, scientists at the University of Rochester Medical Center have shown how stem-cell therapy might someday be used to treat the disease.

For more than a decade, Steve Stice has dedicated his research using embryonic stem cells to improving the lives of people with degenerative diseases and debilitating injuries. His most recent discovery, which produces billions of neural cells from a few stem cells, could now aid in national security.

According to a ruling that Mercer County, N.J., Superior Court Judge Neil Shuster issued on Monday, a referendum that asks voters to approve borrowing $450 million over 10 years to fund stem cell research in the state must remain on the Nov. 6 ballot, the New York Times reports (Peters, New York Times, 9/25).In July, New Jersey Gov.

The New York Stem Cell Foundation’s (NYSCF) second annual Translational Stem Cell Research Conference will be held from October 15-16 at The Rockefeller University in Manhattan. The conference will bring together many of the most prominent figures in human embryonic stem cell (hESC) research from across the United States and abroad.

After a decade of research, Howard Hughes Medical Institute scientists have succeeded in reprogramming adult stem cells from the testes of male mice into functional blood vessels and contractile cardiac tissue. The research offers a promising new source of stem cells for use in organ regeneration studies.